Prevention of Adhesions During Celioscopy for Endometriosis. Impact of the Use of Anti-adhesion Treatment on Clinical Signs and Fertility at One Year

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02612818

Acronym

ENDHY

Enrollment

364

Registered

2015-11-24

Start date

2015-11-24

Completion date

2019-05-31

Last updated

2018-08-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometriosis, Adhesive

Keywords

coelioscopy

Brief summary

Thus is a longitudinal, prospective, multicentric observational study performed in mainland France, among a sample of gynaecology surgeons practising at endometriosis expert centres. The aim of this study is to describe, under real treatment conditions in patients suffering from endometriosis, the impact of the use of anti-adhesion treatment during celioscopy surgery on the development of clinical signs in the patients and their fertility at one year.

Interventions

DEVICECoelioscopy

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Adult patients of procreation age and who have undergone treatment for endometriosis through celioscopic surgery. * Patients for whom spontaneous pregnancy is possible, whether or not they wish to become pregnant immediately. * Patients accepting and able to update a questionnaire in French. * Informed patients who agree to computerised processing of their medical data and their right of access and rectification.

Exclusion criteria

* Patients for whom a medical assistance programme for procreation (IVF, artificial insemination) is currently in progress. * Patients presenting with an absolute or relative contra-indication for use of an anti-adhesion agent (severe allergic antecedents etc). * Patients not wishing to become pregnant. * Patients participating or having participated during the previous month in a gynaecological clinical trial.

Design outcomes

Primary

Measure	Time frame	Description
Change on the clinical signs	At 2 months and one year after the baseline visit (i.e. celioscopy)	The clinical change will be established after one year via the pain symptomatology reported by the patient, the rate of relapse (re-hospitalisation) and the rate of any eventual complications from the celioscopy (adhesions, etc.).
Fertility	One year after the baseline visit (i.e. celioscopy)	rate of pregnancy women

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026